Ngā hua rapu kaituhi

1

Parks in peril: people, politics and protected areas mā Silveira, Pedro Castelo Branco

I whakaputaina 2001

Whiwhi kuputuhi katoa
Online

Tiaki ki tētahi rārangi

I tiakina i:
2

Híbridos na paisagem: uma etnografia de espaços de produção e de conservação mā Silveira, Pedro Castelo Branco

I whakaputaina 2009

Whiwhi kuputuhi katoa
Online

Tiaki ki tētahi rārangi

I tiakina i:
3

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers mā Bernardo P. de Almeida, Joana Apolónio, Alexandra Binnie, Pedro Castelo‐Branco

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects mā Ta‐Chiang Liu, Pedro Castelo‐Branco, Samuel D. Rabkin, Robert L. Martuza

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy mā Ricardo Leão, Célia Domingos, Arnaldo Figueiredo, Robert J. Hamilton, Uri Tabori, Pedro Castelo‐Branco

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer mā Ricardo Leão, Joana Apolónio, Dong‐Hyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo‐Branco

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

CRISPR-based strategies in infectious disease diagnosis and therapy mā Alexandra Binnie, Emanuel Fernandes, Hélder Almeida-Lousada, Ramon Andrade de Mello, Pedro Castelo‐Branco

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Polypyrimidine Tract Binding Protein Modulates Efficiency of Polyadenylation mā Pedro Castelo‐Branco, André Furger, Matthew Wollerton, Christopher W. J. Smith, Alexandra Moreira, Nicholas Proudfoot

I whakaputaina 2004

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

PALOMA-3 clinical trial: is there a significant benefit in overall survival for breast cancer? Is it worth it? mā Jacob J. Adashek, Pedro Nazareth Aguiar, Pedro Castelo‐Branco, Gilberto Lopes, Ramon Andrade de Mello

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
10

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis mā Ramon Andrade de Mello, Carles Escriu, Pedro Castelo‐Branco, Paloma Cabral, Giannis Mountzios, Gilberto Lopes, Pedro Madureira

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Efeitos adversos no tratamento da hanseníase: uma revisão sistemática mā Harley Araujo Espanhol, João Pedro Castelo Branco Hamada, Gabriel Lucas Navarro Antonio, Marilda Aparecida Milanêz Morgado de Abreu

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Hot Topics in Epigenetic Regulation of Cancer Self-Renewal for Pancreatic Tumors: Future Trends mā Ramon Andrade de Mello, Inês Faleiro, Joana Apolónio, Uri Tabori, Aryeh J. Price, Vânia Palma Roberto, Pedro Castelo‐Branco

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Editorial

Tiaki ki tētahi rārangi

I tiakina i:
13

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives mā Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Victor André de Almeida Zia

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway mā Ramon Andrade de Mello, Pedro Nazareth Aguiar, Hakaru Tadokoro, Tállita Meciany Farias-Vieira, Pedro Castelo‐Branco, Gilberto Lopes, Daniel Humberto Pozza

I whakaputaina 2018

Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
15

Cellular Interactions in the Tumor Microenvironment: The Role of Secretome mā Bianca Rodrigues da Cunha, Célia Domingos, Ana Carolina Buzzo Stefanini, Tiago Henrique, Giovana Mussi Polachini, Pedro Castelo‐Branco, Eloíza H. Tajara

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives mā Ramon Andrade de Mello, Rafael Voscaboinik, João Vittor Pires Luciano, Rafaela Vilela Cremonese, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Γεώργιος Αντωνίου

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers? mā Hélder Almeida-Lousada, André Mestre, Sara Ramalhete, Aryeh J. Price, Ramon Andrade de Mello, Ana Marreiros, Ricardo Pires das Neves, Pedro Castelo‐Branco

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer mā Ramon Andrade de Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Γεώργιος Αντωνίου

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice? mā Ramon Andrade de Mello, Jinhui Zhu, Jairo Iavelberg, Artur Henrique Potim, Débora Simonetti, José Antônio Silva, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Maria Tolia, Georgio Antoniou

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
20

Bifosfonatos: tipos, mecanismos de ação e efeitos colaterais. Revisão da literatura para orientação de profissionais e estudantes das áreas médica e odontológica mā Viviann Ruocco Vetucci, Monique Bergantim, Daniel Pedro Castelo Branco Lopes, Diego Nunes Pim, Gustavo Junqueira de Almeida, Rodrigo Nascimento Turano de Mattos, Tiago Varesche Silva, Ana Paula de Souza Faloni

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Pedro Castelo‐Branco

Parks in peril: people, politics and protected areas mā Silveira, Pedro Castelo Branco

Híbridos na paisagem: uma etnografia de espaços de produção e de conservação mā Silveira, Pedro Castelo Branco

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers mā Bernardo P. de Almeida, Joana Apolónio, Alexandra Binnie, Pedro Castelo‐Branco

Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects mā Ta‐Chiang Liu, Pedro Castelo‐Branco, Samuel D. Rabkin, Robert L. Martuza

Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy mā Ricardo Leão, Célia Domingos, Arnaldo Figueiredo, Robert J. Hamilton, Uri Tabori, Pedro Castelo‐Branco

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer mā Ricardo Leão, Joana Apolónio, Dong‐Hyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo‐Branco

CRISPR-based strategies in infectious disease diagnosis and therapy mā Alexandra Binnie, Emanuel Fernandes, Hélder Almeida-Lousada, Ramon Andrade de Mello, Pedro Castelo‐Branco

Polypyrimidine Tract Binding Protein Modulates Efficiency of Polyadenylation mā Pedro Castelo‐Branco, André Furger, Matthew Wollerton, Christopher W. J. Smith, Alexandra Moreira, Nicholas Proudfoot

PALOMA-3 clinical trial: is there a significant benefit in overall survival for breast cancer? Is it worth it? mā Jacob J. Adashek, Pedro Nazareth Aguiar, Pedro Castelo‐Branco, Gilberto Lopes, Ramon Andrade de Mello

Efeitos adversos no tratamento da hanseníase: uma revisão sistemática mā Harley Araujo Espanhol, João Pedro Castelo Branco Hamada, Gabriel Lucas Navarro Antonio, Marilda Aparecida Milanêz Morgado de Abreu

Hot Topics in Epigenetic Regulation of Cancer Self-Renewal for Pancreatic Tumors: Future Trends mā Ramon Andrade de Mello, Inês Faleiro, Joana Apolónio, Uri Tabori, Aryeh J. Price, Vânia Palma Roberto, Pedro Castelo‐Branco

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives mā Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Victor André de Almeida Zia

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway mā Ramon Andrade de Mello, Pedro Nazareth Aguiar, Hakaru Tadokoro, Tállita Meciany Farias-Vieira, Pedro Castelo‐Branco, Gilberto Lopes, Daniel Humberto Pozza

Cellular Interactions in the Tumor Microenvironment: The Role of Secretome mā Bianca Rodrigues da Cunha, Célia Domingos, Ana Carolina Buzzo Stefanini, Tiago Henrique, Giovana Mussi Polachini, Pedro Castelo‐Branco, Eloíza H. Tajara

Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers? mā Hélder Almeida-Lousada, André Mestre, Sara Ramalhete, Aryeh J. Price, Ramon Andrade de Mello, Ana Marreiros, Ricardo Pires das Neves, Pedro Castelo‐Branco

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer mā Ramon Andrade de Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Γεώργιος Αντωνίου

Ngā utauta rapu:

Ngā marau whai pānga